biomedicina slovenica

id=100171 : 1

1. Bonnefoi H; Biganzoli L; Mauriac L; Čufer T; Schaefer P; Atalay G; Piccart M
   An EORTC phase I study of capecitabine (xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer
   2003 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics